✓
Open
15 May 2024
✓
Close
17 May 2024
3
Allotment
—
✓
Listing
Thu, May 23, 2024
Price Band
₹93 to ₹97
Issue Size
44,49,600 shares (agg. up to ₹43 Cr)
Lot Size
1,200 Shares
Listing Date
Thu, May 23, 2024
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 61.57x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 58.69 | 46.65 | 34.80 | 18.40 |
| Total Income | 62.18 | 61.87 | 59.54 | 30.44 |
| Profit After Tax | 7.75 | 5.03 | 4.11 | 0.66 |
| NET Worth | 22.77 | 15.02 | 9.99 | 5.89 |
| Reserves and Surplus | 11.98 | 13.94 | 8.92 | 4.81 |
| Total Borrowing | 4.61 | 4.10 | 3.13 | 3.04 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Zenith Drugs Ltd. | SME | ₹40.68 Cr | ₹79 | 18.4 | ₹105.15 | +33.10% | ₹50.10 (-4.48%) |
| Sunrest Lifescience Ltd. | SME | ₹10.85 Cr | ₹84 | 12.33 | ₹79.80 | -5.00% | ₹35.00 (-1.69%) |
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹10.75 (+4.88%) |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹26.00 (+1.96%) |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹42.25 (-4.52%) |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹737.40 (-0.29%) |
| Innova Captab Ltd. | Mainboard | ₹570.00 Cr | ₹448 | 31.64 | ₹541.40 | +20.85% | ₹1,011.30 (+2.04%) |
| Blue Jet Healthcare Ltd. | Mainboard | ₹840.27 Cr | ₹346 | 37.49 | ₹413.40 | +19.48% | ₹588.15 (-1.65%) |
| Valiant Laboratories Ltd. | Mainboard | ₹152.46 Cr | ₹140 | 15.71 | ₹170.25 | +21.61% | ₹63.60 (-1.68%) |
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,346.00 (+0.23%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility | 26.00 |
| 2 | Funding Working Capital Requirements of the Company | 10.00 |
| 3 | General corporate purposes | 3.38 |
About Quest Laboratories IPO
Incorporated in June 1998, Quest Laboratories Limited is a pharmaceutical company manufacturing a range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company operates in the domestic market across twelve (12) states and two (2) union territories. These include Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar. The manufacturing unit of the company is located in Dhar, Madhya Pradesh. The company holds WHO Schedule M GMP and GLP certifications, as well as ISO/IEC 17025:2017 and ISO 9001:2015 certifications. By December 31st, 2023, the company employs 83 individuals to lookafter various aspects of its manufacturing operations, including production, quality control, technical and engineering support services, inventory management, administration, accounting, and other functions such as storage, packing, and dispatch.+ Read More
Contact Details
Quest Laboratories Ltd. AddressPlot No.45, Sector IIIPithampur Industrial AreaPithampurDhar, Madhya Pradesh, 45477507292292374investors@questlabltd.comVisit Website